as on October 31, 2025 at 1:29 am IST
Day's Low
Day's High

4.42%
Downside
7.08%
Upside

52 Week's Low
52 Week's High

73.89%
Downside
840.15%
Upside

Check Applied Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$188.7M
EPS (TTM)
-0.5733
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-111.4M
Revenue (TTM)
121.0K
Profit Margin
0.00%
Return On Equity TTM
-150.82%
Compare market cap, revenue, PE, and other key metrics of Applied Therapeutics Inc with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| BUY | $188.7M | NA | NA | 0.00% | |
| BUY | $62.4B | 291.63% | -505.15 | -12.96% | |
| NA | $36.4B | NA | NA | -3.89% | |
| BUY | $108.3B | 100.24% | 30.02 | 31.86% | |
| BUY | $69.4B | 20.12% | 15.7 | 32.13% | 
The Applied Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Applied Therapeutics Inc investment value today
Current value as on today
₹18,180
Returns
Returns from Applied Therapeutics Inc Stock
Dollar Returns*
₹5,667 (+5.67%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Applied Therapeutics Inc. Average target price of $3.17
Get share price movements and forecasts by analysts on Applied Therapeutics Inc.
What analysts predicted
64.35%UPSIDE
Target Price
$3.17
Current Price
$1.13
Analyzed by
11 Analysts
Target
$3.17
Applied Therapeutics Inc target price $3.17, a slight upside of 64.35% compared to current price of $1.13. According to 11 analysts rating.
Investment in Applied Therapeutics Inc Shares on INDmoney has grown by 220.27% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:220.27% versus previous 30 day period
Search interest for Applied Therapeutics Inc Stock has increased by 283% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:283% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 POSITIVE IMPACT
POSITIVE IMPACTPrice Rise

In the last 1 month, APLT stock has moved up by 101.7%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 80.6% return, outperforming this stock by 166.8%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 132.4% return, outperforming this stock by 74.8%
| Organisation | Applied Therapeutics Inc | 
| Headquarters | 545 Fifth Avenue, New York, NY, United States, 10017 | 
| Industry | Biotechnology | 
| CEO | Mr. Les D. Funtleyder | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Dr. Evan Prescott Bailey M.D. | Chief Medical Officer | 
| Ms. Dottie Caplan | Executive Vice President of Patient Advocacy & Government Affairs. | 
| Mr. John H. Johnson | Executive Chairman | 
| Mr. Les D. Funtleyder | Interm CEO, CFO, Principal Financial Officer & Director | 
| Mr. Corwin Dale Hooks | Chief Commercial Officer | 
| Mr. Constantine Chinoporos | COO & Chief Business Officer | 
| Dr. Todd F. Baumgartner M.D., M.P.H. | Chief Regulatory Officer | 
| Ms. Catherine Thorpe | Interim Chief Accounting Officer | 
| Ms. Reena Thomas Colacot | Head of Quality | 
Applied Therapeutics Inc share price today is $1.13 as on at the close of the market. Applied Therapeutics Inc share today touched a day high of $1.21 and a low of $1.08.
Applied Therapeutics Inc share touched a 52 week high of $10.62 on and a 52 week low of $0.3 on . Applied Therapeutics Inc stock price today i.e. is closed at $1.13,which is 89.36% down from its 52 week high and 283.05% up from its 52 week low.
Applied Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Applied Therapeutics Inc (APLT) shares with as little as ₹88.686 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.86 in Applied Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Applied Therapeutics Inc share’s latest price of $1.13 as on October 31, 2025 at 1:29 am IST, you will get 8.8496 shares of Applied Therapeutics Inc. Learn more about
          
            fractional shares .